What's Happening

Stay up to date on conferences, social posts, and what’s new with Healthesystems

Events

Let’s connect at one of our upcoming conferences or speaking engagements

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Zoryve (roflumilast) cream

Approval Date: Jul 2022

Note: New Product

Indicated for topical treatment of plaque psoriasis

hello world!

Zonisade (zonisamide) oral suspension

Approval Date: Jul 2022

Note: New Dosage or Formulation

Indicated as an adjunctive therapy for the treatment of partial-onset seizures, this approval is for the first liquid formulation of zonisamide.

hello world!

Briviact (brivaracetam) tablets

Approval Date: Jun 2022

Note: First-Time Generic

Indicated for the treatment of partial-onset seizures.

hello world!

Riabni (rituximab-arrx)

Approval Date: Jun 2022

Note: New Indication

A biosimilar to Rituxan® with existing oncology indications, this drug is now approved for the treatment of moderate-to-severe rheumatoid arthritis, in combination with methotrexate.

hello world!

Skyrizi® (risankizumab-rzza) injection

Approval Date: Jun 2022

Note: New Indication

Approved for its third indication for moderately to severely active Crohn’s disease, in addition to existing indications for moderate-to-severe plaque psoriasis and active psoriatic arthritis.

hello world!

Vtama® (tapinarof) cream

Approval Date: May 2022

Note: New Product

A steroid-free topical indicated for treatment of plaque psoriasis

hello world!

Olumiant® (baricitinib)

Approval Date: May 2022

Note: New Product

Indicated for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, and other assistance with breathing

hello world!

Mounjaro (tirzepatide) injection

Approval Date: May 2022

Note: New Product

Indicated for the improvement of glycemic control in patients with type 2 diabetes, in conjunction with diet and exercise

hello world!

Igalmi (dexmedetomidine) sublingual film

Approval Date: Apr 2022

Note: New Product

Indicated for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder

hello world!

Vimpat (lacosamide) tablets

Approval Date: Mar 2022

Note: First-Time Generic

A first-time generic for Vimpat, this drug treats partial onset seizures

hello world!
1 4 5 6 7 8 11

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmagnifiermenucross-circle